Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 21.12
  • 0.49  -2.27%
    Today's Change
  • 21.61
    Previous Close
  • Today
    52 Week Low - High
3:39 pm ET 10/21/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding37 million
Market Cap$794 million
Return on Equity ttm2.88%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm0.562
EPS: Year Est. 12/14 ttm0.907
EPS: Quarterly Actual 6/14 0.13
EPS: Quarterly Est. 9/14 0.47
Price/Earnings ttm37.68
Relative Price/Earnings2.209
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!